Star Voice Of India 2008 Winner Ishmeet Singh Died in Maldives

‘Voice of India’ singing contest winner Ishmeet Singh Tuesday died under mysterious circumstances by “drowning” in a swimming pool in Male, the capital of the Maldives.

The 19-year-old singer hailing from a middle-class of this industrial city of Punjab had gone to Maldives for a promotional event with the music company with which he had a contract.



Relatives at his residence here said the family was informed telephonically by the music company officials that Ishmeet died while swimming in a hotel pool in the Maldives.

Relatives, friends and admirers of the singer made a beeline to his house even as his shocked parents tried to come to terms with the untimely tragedy. A pall of gloom descended on the locality.

The singer left here Tuesday morning for Maldives from Mumbai.

Ishmeet had Nov 26 last year won the ‘Voice of India’ singing contest, pipping his closest rival Harshit from Uttar Pradesh in a keen contest. He was given the winner’s trophy by melody queen Lata Mangeshkar.

Supporters of the singer voted heavily for him from Punjab during the finals of the contest. Even though Harshit led the votes tally in most regions of the country, the final count went in Ishmeet’s favour due to heavy voting from Punjab.

“He was like a brother to me. I cannot even comment on what has happened. I cannot believe that he is no longer with us,” fellow contestant Harshit told a TV news channel.

Federal Agency Approves Use Of Generic Wellbutrin In Depression Patients

The U.S. Food and Drug Administration said Wednesday that a generic version of a popular name brand antidepressant is both safe and effective, despite recent consumer complaints



The federal agency reviewed the generic version of Wellbutrin manufactured by Teva after some patients reported their depression returned when they switched from the brand name drug Wellbutrin XL to the generic pharmaceutical. Some patients also complained of headaches, anxiety and other side effects.

After evaluating the reports concerning the generic version of bupropion hydrochloride extended-release 300-milligram tablets, the FDA said in its report that the generic product is "a safe and effective choice for consumers in treating depression, as it has been shown to meet all requirements for approval, including bioequivalence to the branded drug, Wellbutrin XL 300-milligram."

In a report posted online, FDA concluded the reoccurrence of depression and other side effects are typical of patients taking antidepressants.

Wellbutrin XL is owned by GlaxoSmithKline of Philadelphia, and manufactured by Biovail of Mississauga, Ontario. Budeprion XL is manufactured by Impax Laboratories of Hayward, Calif., and distributed by Teva Pharmaceuticals of North Wales, Pa.